N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies

Ming Lung Ho, Wei Ke Kuo, Lichieh J. Chu, I. Hsin Yeh, Chung Wei Fan, Hsin I. Chang, Cho Li Yuan, Ting Yu Chou, Hoang Yang Chen, Shih Wei Yang, Liang Che Chang, Minzhen Luo, Timothy H. Wu, Yi Feng I. Chang, Chia Jung Yu, Chung Ching Hua, Wailap V. Ng*


研究成果: Article同行評審

7 引文 斯高帕斯(Scopus)


Background/Aim: The aim of this study was to evaluate N-acetylgalactosamine-6-sulfatase (GALNS) as a new biomarker candidate for detecting lung cancer. Glycodelin or PAEP, the serum levels of which are known to be elevated in lung and other cancers, served as a benchmark for comparison. Patients and Methods: A total of 170 serum samples from healthy controls and patients with pneumonia, lung cancer, breast cancer, colon cancer, liver cancer, and head and neck cancer were analyzed for the levels of GALNS and PAEP by ELISA. Results: The median serum levels of GALNS and PAEP in all cancer types as well as pneumonia patients were significantly higher than those of the healthy controls. Conclusion: In addition to previously known cancers, the median serum levels of PAEP were also found to be higher in liver and head and neck cancer patients. GALNS and PAEP are promising general biomarkers for multiple cancers and deserve further evaluation.

頁(從 - 到)6317-6324
期刊Anticancer Research
出版狀態Published - 2019


深入研究「N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies」主題。共同形成了獨特的指紋。